Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-110-5 | CAS number: 64742-10-5 A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly higher than C25.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 1988-02-16 to 1988-05-24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable without restriction because it is a well-documented study report following sound scientific principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1998
Materials and methods
- Principles of method if other than guideline:
- Method: other: micronucleus assay of bone marrow
- GLP compliance:
- not specified
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- most likely CAS # 64742-10-5
- IUPAC Name:
- most likely CAS # 64742-10-5
- Details on test material:
- Residual Aromatic Extract, Mobilsol 40 (C.T. 28) M.I.0.4.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- IN-LIFE DATES: From: 1988-02-18 To: 1988-05-24
Administration / exposure
- Route of administration:
- dermal
- Vehicle:
- None
- Details on exposure:
- No data reported.
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- Once per day, five days per week
- Post exposure period:
- None
Doses / concentrations
- Remarks:
- Doses / Concentrations:
500, 2000 mg/kg bw/day
Basis:
other: dermal exposure
- No. of animals per sex per dose:
- 10 per sex per dose
- Control animals:
- yes, concurrent no treatment
- Positive control(s):
- None
Examinations
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: No data provided
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): Bone marrow was harvested after the 13-week dosing period.
DETAILS OF SLIDE PREPARATION: Femurs were taken from five animals per sex per group with three slides made per animal. Slides were stained according to procedures of R. R. Tice, air dried, and fixed in absolute methanol for 15 minutes. After drying, slides were placed in acridine orange solution for 7 minutes, rinsed in Giordano's buffer solution for 10 minutes. Slides were randomized, and one thousand polychromatic erythrocytes and one thousand normochromatic erythrocytes were analyzed for micronucleus formation using fluorescence microscopy.
METHOD OF ANALYSIS: Bone marrow cells were analyzed for micronucleus formation. - Evaluation criteria:
- If ratio of polychromatic and monochromatic erythrocytes in test animal cells did not differ from control, then cytotoxicity was not judged to be a factor in cytogenetic effects.
- Statistics:
- SAS ANOVA, ANOVA F Test, Tukey's Studentized Range Test, Scheffe's Test, and SAS General Linear Model were applied to the data.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Additional information on results:
- Cytotoxicity was not a factor in micronucleus induction because the mean ratios of polychromatic to monochromatic in the dose groups were not significantly different from each other or the control group.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Under conditions of the study, residual aromatic extract does not induce a significant increase in micronuclei formation in bone marrow erythrocytes compared to controls. - Executive summary:
In an in vivo micronucleus study, male and female Sprague Dawley rats (10/sex/dose) were treated dermally with residual aromatic extract once daily, five days per week for 13 weeks at dose levels of 0, 500, or 2000 mg/kg/day. At the end of the 13 -week treatment period, bone marrow was harvested from the femur of 5 animals per sex per dose and analyzed for induction of micronucleus formation. There was no difference in the percentage of micronucleated cells in the treated animals versus the controls when analyzed by SAS ANOVA and SAS GLM (General Linear Model). Therefore, residual aromatic extract does not induce a significant increase in micronucleus formation over untreated controls.
This study recieved a Klimisch score of 1 and is classified as reliable without restriction because it is a well-documented study report that followed basic scientific principles.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
På den här webbplatsen används kakor. Syftet är att optimera din upplevelse av den.